ENZON PHARMACEUT.
Share · US2939041081 · 873997 (XNCM)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ENZON PHARMACEUT.
No Price
28.04.2026 20:00
Current Prices from ENZON PHARMACEUT.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
 UTC |
ENZN
|
USD
|
28.04.2026 20:00
|
6,00 USD
| -0,65 USD
-9,77 %
|
Company Profile for ENZON PHARMACEUT. Share
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
Company Data
Name ENZON PHARMACEUT.
Company Enzon Pharmaceuticals, Inc.
Website
https://www.enzon.com
Primary Exchange
NASDAQ CAPITAL MARKET
NASDAQ CAPITAL MARKET
WKN 873997
ISIN US2939041081
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Richard L. Feinstein CPA
Country United States of America
Currency EUR
Employees -
Address 20 Commerce Drive, 07016 Cranford
IPO Date 1984-02-15
Dividends from 'ENZON PHARMACEUT.'
| Ex-Date | Dividend per Share |
|---|---|
| 30.09.2019 | 0,12 USD |
| 20.02.2019 | 0,06 USD |
| 29.09.2017 | 0,15 USD |
| 13.12.2016 | 0,15 USD |
| 30.12.2015 | 0,25 USD |
| 13.08.2015 | 0,50 USD |
| 08.01.2015 | 0,10 USD |
| 24.12.2013 | 0,45 USD |
| 05.06.2013 | 1,60 USD |
| 03.05.2013 | 1,60 USD |
Stock Splits
| Date | Split |
|---|---|
| 25.03.2026 | 1:100 |
| 29.09.2017 | 1:1 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | ENZN |
| Düsseldorf | EPIRSD81.DUSB |
More Shares
Investors who hold ENZON PHARMACEUT. also have the following shares in their portfolio:
